Core Viewpoint - Catheter Precision, Inc. has acquired heart failure-related assets from Cardionomic, Inc., marking a significant milestone in expanding its product offerings in the cardiac electrophysiology market [1][2][3] Group 1: Acquisition Details - The acquisition involves certain assets related to a new therapy for acute decompensated heart failure (ADHF), a condition affecting over 1 million Americans annually [2] - The CPNS System, developed by Cardionomic, utilizes electrical stimulation via a temporary catheter in the pulmonary artery to target the root cause of heart failure [2] - Initial studies of the CPNS System have shown positive results, indicating potential for effective treatment options [2] Group 2: Company Overview - Catheter Precision is focused on developing innovative medical devices aimed at improving the treatment of cardiac arrhythmias [3] - The company collaborates with physicians to advance its products and bring new solutions to market [3]